Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus

AIMS: LY2963016 (LY IGlar) and Lantus (IGlar) are insulin glargine products manufactured by distinct processes, but with identical amino acid sequences. This study compared the duration of action of LY IGlar and IGlar in subjects with type 1 diabetes mellitus (T1DM). MATERIALS AND METHODS: This was...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes Obes Metab
Hauptverfasser: Linnebjerg, Helle, Lam, Eric Chen Quin, Zhang, Xin, Seger, Mary E., Coutant, David, Chua, Laiyi, Kapitza, Christoph, Heise, Tim
Format: Artigo
Sprache:Inglês
Veröffentlicht: Blackwell Publishing Ltd 2016
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215447/
https://ncbi.nlm.nih.gov/pubmed/27484286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12759
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge